Search

everythinglearnresearchcommunity

for

Search:↓

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Daily low-dose aspirin lowers minoxidil's effectiveness for hair loss treatment.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Finasteride helps hair growth but may cause sexual side effects and depression.

Topical booster improves hair loss treatment effectiveness.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

New treatments for skin and hair repair show promise, but further improvements are needed.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Some medications can cause acne, and stopping these drugs is the main treatment.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Dutasteride helps hair growth in those unresponsive to finasteride, but may cause more sexual dysfunction.

Genetically-altered adult stem cells can help in wound healing and are becoming crucial in regenerative medicine and drug design.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.